Sat.Oct 10, 2020

article thumbnail

New patent expiration for Glaxo Grp drug ADVAIR HFA

Drug Patent Watch

Annual Drug Patent Expirations for ADVAIR+HFA Advair Hfa is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from one supplier. There areā€¦. The post New patent expiration for Glaxo Grp drug ADVAIR HFA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59
article thumbnail

Oncotarget: Cooperative tumorigenic effects of targeted deletions of tumor suppressors

Scienmag

Volume 11, Issue 28 of Oncotarget features “Genetic analysis of the cooperative tumorigenic effects of targeted deletions of tumor suppressors Rb1, Trp53, Men1, and Pten in neuroendocrine tumors in mice” by Xu et, al. which reported that the authors exami Credit: Correspondence to – Eugenia Y. Xu – exu@princeton.edu and Daniel A.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New patent expiration for Glaxo Grp drug FLOVENT HFA

Drug Patent Watch

Annual Drug Patent Expirations for FLOVENT+HFA Flovent Hfa is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from three suppliers. There areā€¦. The post New patent expiration for Glaxo Grp drug FLOVENT HFA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59
article thumbnail

When Should You Update Your Resume For Clinical Research?

ECRG Media's Clinical Research Podcast

When Should You Update Your Resume For Clinical Research? Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: Ā» Industry News: [link] Ā» All Videos: [link] Ā» Interview Recaps: [link] Ā» Glassdoor Reviews: [link] We do: Ā» Insider Interviews Ā» Resume Reviews Ā» Question and Answer Ā» Discuss all things Clinical Research Ā» News and Product Reviews Ā» Educ

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

A new approach to mental health ā€“ the Health Heroes podcast

pharmaphorum

The third episode of Kantar’s Health Heroes podcast looks at the effects of increased anxiety on patientsā€™ attitudes and behaviours during the pandemic and how approaches to mental health in the US need to change. Lynnette Cooke, global CEO of Kantar Health, and noted population health expert Dr David Nash from Thomas Jefferson University join Dominic Tyer to assess some of the mental health impacts of COVID-19 in the US.

article thumbnail

When Should You Update Your Resume For Clinical Research?

ECRG Media's Clinical Research Podcast

When Should You Update Your Resume For Clinical Research? Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: Ā» Industry News: [link] Ā» All Videos: [link] Ā» Interview Recaps: [link] Ā» Glassdoor Reviews: [link] We do: Ā» Insider Interviews Ā» Resume Reviews Ā» Question and Answer Ā» Discuss all things Clinical Research Ā» News and Product Reviews Ā» Educ

More Trending

article thumbnail

Dr. Mark Mofid, M.D Update: Brazilian Butt Lift Surgery in the Spotlight Again

BioTech 365

La Jolla, California, Oct. 10, 2020 (GLOBE NEWSWIRE) — “The risks associated with fat grafting to the buttocks (commonly referred to as BBL surgery) are highlighted by La Jolla, California plastic surgeon, Dr.

40
article thumbnail

Which pharmaceutical companies have the most drug patents in Hungary?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Hungary. Patents must be filed in each country (or, in some cases regional patent office) where patent protection isā€¦. The post Which pharmaceutical companies have the most drug patents in Hungary? appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

New data presented at UEG Week Virtual 2020 show positive association between RemsimaĀ® SC pre-dose level with efficacy outcomes

BioTech 365

Data show positive association between subcutaneous infliximab (Remsima® SC / CT-P13 SC) exposure with efficacy and fecal calprotectin (FC) outcomes in patients with active Crohn’s disease (CD) and ulcerative colitis (UC)1 These findings suggest that higher SC infliximab pre-dose levels … Continue reading →

52
article thumbnail

Can Trump Really Speed Approval of Covid Treatments?

NY Times

Emergency-use authorizations, a formerly obscure corner of regulatory law, have become a centerpiece of the governmentā€™s response to the pandemic.

66
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Bristol Myers Squibb Presents Positive Late-Breaking Data from Phase 3 True North Trial Evaluating Zeposia (ozanimod) in Adult Patients with Moderate to Severe Ulcerative Colitis

BioTech 365

Both primary and all key secondary efficacy endpoints showed statistically significant improvements with oral Zeposia versus placebo at Week 10 and Week 52 No new safety signals were observed with Zeposia in the True North study Results to be presented … Continue reading →

Trials 52